Literature DB >> 27694451

Incidence and Risk Factors for Major Surgical Site Infections in Aesthetic Surgery: Analysis of 129,007 Patients.

Christodoulos Kaoutzanis1, Varun Gupta2, Julian Winocour2, Bruce Shack2, James C Grotting2, Kent Higdon2.   

Abstract

BACKGROUND: Surgical site infections (SSIs) represent one of the most common postoperative complications in patients undergoing aesthetic surgery.
OBJECTIVES: This study reports the incidence and risk factors of major SSIs following aesthetic surgery.
METHODS: A prospective cohort of patients who underwent aesthetic surgery between 2008 and 2013 was identified from the CosmetAssure database. Primary outcome was occurrence of a major SSI requiring emergency room visit, hospital admission, or reoperation within 30 days of the index operation. Univariate and multivariate analysis evaluated potential risk factors for SSIs including age, gender, body mass index (BMI), smoking, diabetes, type of surgical facility, procedure by body region, and combined procedures.
RESULTS: A total of 129,007 patients were identified, of which 599 (0.46%) had a major SSI. Mean age (43.8 ± 12.4 years vs 40.9 ± 13.9 years, P < .01) and BMI (27.3 ± 5.5 kg/m2 vs 24.3 ± 4.6 kg/m2, P < .01) were higher in patients with SSIs. Patients with a SSI were more likely to be smokers (10.5% vs 8.2%, P = .04) and diabetic (4.5% vs 1.8%, P < .01). Females suffered more SSI than males (0.5% vs 0.3%, P = .02). Trunk/extremity procedures had a higher incidence of SSI compared to breast or face procedures (0.9% vs 0.2%, P < .01). On multivariate analysis, independent predictors of SSI included age (Relative Risk [RR] 1.01), female gender (RR 1.86), BMI (RR 1.07), smoking (RR 1.61), diabetes (RR 1.58), hospital or ambulatory surgery center procedures (RR 1.39), trunk/extremity procedures (RR 2.42), and combined procedures (RR 1.88).
CONCLUSIONS: SSIs following cosmetic surgical procedures are associated with numerous independent predictors, which should be taken into consideration when counseling patients undergoing aesthetic surgery. LEVEL OF EVIDENCE: 2 Risk.
© 2016 The American Society for Aesthetic Plastic Surgery, Inc. Reprints and permission: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2016        PMID: 27694451     DOI: 10.1093/asj/sjw100

Source DB:  PubMed          Journal:  Aesthet Surg J        ISSN: 1090-820X            Impact factor:   4.283


  4 in total

1.  The Role of Topical Antibiotic Prophylaxis in Oculofacial Plastic Surgery: A Randomized Controlled Study.

Authors:  Davin C Ashraf; Oluwatobi O Idowu; Qinyun Wang; Tak YeEun; Thomas S Copperman; Sombat Tanaboonyawat; Benjamin F Arnold; Catherine E Oldenburg; M Reza Vagefi; Robert C Kersten
Journal:  Ophthalmology       Date:  2020-07-19       Impact factor: 12.079

2.  Electronically Available Comorbidities Should Be Used in Surgical Site Infection Risk Adjustment.

Authors:  Sarah S Jackson; Surbhi Leekha; Laurence S Magder; Lisa Pineles; Deverick J Anderson; William E Trick; Keith F Woeltje; Keith S Kaye; Timothy J Lowe; Anthony D Harris
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

3.  Obesity: is it an additional risk factor in analyzing surgical outcomes in the South Indian population?

Authors:  Divya Karanth; Veena L Karanth
Journal:  J Prev Med Hyg       Date:  2021-04-29

Review 4.  Plastic Surgery Complications: A Review for Emergency Clinicians.

Authors:  Tim Montrief; Kasha Bornstein; Mark Ramzy; Alex Koyfman; Brit J Long
Journal:  West J Emerg Med       Date:  2020-09-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.